Clinical Trials Browser

Cachexia, Neoplasms

NCT07516210 2026-04-07

ART-Hypo

Phase 2 Not yet recruiting

264 enrolled

GastrointestinalGenitourinaryGynecologic

Uterine Cervical Neoplasms, Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07487805 2026-03-23

ICONIC

Phase 2 Not yet recruiting

80 enrolled

Tumor-Agnostic

Neoplasms

NCT07102940 2026-02-20

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Phase 2 Not yet recruiting

50 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT07405736 2026-02-12

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

124 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07406789 2026-02-12

LUMInova

Phase 2 Not yet recruiting

100 enrolled

Breast

Breast Neoplasms, Neoplasms

NCT07346677 2026-02-02

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Phase 2 Not yet recruiting

190 enrolled

Neoplasms, Phlebitis

NCT07378761 2026-01-30

CHILURSO

Phase 2 Not yet recruiting

94 enrolled

Tumor-Agnostic

Neoplasms

NCT07354919 2026-01-21

AxeCan

Phase 2 Not yet recruiting

34 enrolled

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT07356791 2026-01-21

REBIRTH-013

Phase 2 Not yet recruiting

18 enrolled

Tumor-Agnostic

Neoplasms

NCT07126561 2026-01-08

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

Phase 2 Not yet recruiting

43 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07277777 2026-01-06

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

Phase 2 Not yet recruiting

90 enrolled

Neoplasms, Recurrence

NCT07279532 2025-12-12

Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System

Phase 2 Not yet recruiting

35 enrolled

Tumor-Agnostic

Neoplasms

NCT07274384 2025-12-10

HYPERBOLIC

Phase 2 Not yet recruiting

74 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

NCT04181463 2025-10-31

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Phase 2 Not yet recruiting

112 enrolled

Tumor-Agnostic

Neoplasms

NCT04266275 2025-10-29

Topical Curcumin for HPV Related Cervical Disease

Phase 2 Not yet recruiting

200 enrolled

Gynecologic

Uterine Cervical Neoplasms, Communicable Diseases, Neoplasms

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

40 enrolled

CNS

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT07168226 2025-09-11

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

Phase 2 Not yet recruiting

135 enrolled

Cachexia, Neoplasms

NCT07142200 2025-08-26

DECIDING

Phase 2 Not yet recruiting

45 enrolled

Tumor-Agnostic

Neoplasms

NCT07077564 2025-07-22

SKB264-II-NEN

Phase 2 Not yet recruiting

35 enrolled

Tumor-Agnostic

Neoplasms

NCT07041788 2025-06-27

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

Phase 2 Not yet recruiting

25 enrolled

Tumor-Agnostic

Neoplasms

NCT06936748 2025-06-17

SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors

Phase 2 Not yet recruiting

30 enrolled

Tumor-Agnostic

Neoplasms

NCT06862323 2025-06-13

Time Restricted Eating in Haematological Malignancies

Phase 2 Not yet recruiting

75 enrolled

LymphoidOther hematologic neoplasm

Intermittent Fasting, Inflammation, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07018063 2025-06-12

YOUNG-NEOS

Phase 2 Not yet recruiting

35 enrolled

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT07002502 2025-06-10

Immune Modulation With PRaG-1 Treatment

Phase 2 Not yet recruiting

19 enrolled

Tumor-Agnostic

Neoplasms

NCT06904300 2025-06-05

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Phase 2 Not yet recruiting

110 enrolled

Tumor-Agnostic

Neoplasms

NCT06589830 2025-05-15

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Phase 2 Not yet recruiting

80 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT06891521 2025-03-24

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Phase 2 Not yet recruiting

123 enrolled

Tumor-Agnostic

Neoplasms

NCT06495515 2024-07-10

Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study

Phase 2 Not yet recruiting

36 enrolled

Tumor-Agnostic

Neoplasms

NCT05754801 2023-03-09

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer

Phase 2 Not yet recruiting

172 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

FMT-CACH

ART-Hypo

ICONIC

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal Cancer

LUMInova

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

CHILURSO

AxeCan

REBIRTH-013

Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers

125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors

Clinical Study of Adjuvant Surufatinib Therapy for Postoperative High-risk Neuroendocrine Tumors Based on the Ninth Edition of the AJCC Staging System

HYPERBOLIC

Nasal Inhalation of Isopropyl Alcohol for the Treatment of Nausea in Patients With Cancer

Topical Curcumin for HPV Related Cervical Disease

EViDENCE-BT

Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101

DECIDING

SKB264-II-NEN

Iparomlimab and Tuvonralimab Combined With SFRT and Definitive Chemoradiotherapy in Locoregionally Advanced Bulky HNSCC

SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors

Time Restricted Eating in Haematological Malignancies

YOUNG-NEOS

Immune Modulation With PRaG-1 Treatment

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

TL938 and Trastuzumab for Patients With HER2-positive Metastatic Colorectal Cancer

Electroacupuncture for Preventing Adverse Events of Cancer Immunotherapy

Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study

Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer